European Society for Medical Oncology

Immunotherapy set to revolutionise cancer treatment

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland ...

Nov 21, 2014
popularity 3.7 / 5 (9) | comments 0

Immune-response genes affecting breast tumor eradication

Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression ...

May 03, 2012
popularity 5 / 5 (1) | comments 0

New data on combination treatments for melanoma

Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according ...

Sep 29, 2014
popularity not rated yet | comments 0

The true costs of cancer in Europe revealed

New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Sep 28, 2012
popularity not rated yet | comments 0

Spin and bias in published studies of breast cancer trials

Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of ...

Jan 09, 2013
popularity not rated yet | comments 0 | with audio podcast